Because there is a deficiency of CD59 GPI anchored proteins in AD brains[7] due to the cleavage of these proteins from brain cells, it is possible that the CD59 proteins flow into the CSF and plasma when the blood–brain-barrier BBB is damaged in AD patients. The gene discussed is CD59; the disease is Alzheimer disease.